News Focus
News Focus
icon url

JerryCampbell

05/23/22 2:02 PM

#477589 RE: HappyLibrarian #477582

nwbo's data just isn't all that impressive.

That simple statement explains:

- 70 cent stock price
- lack of media interest
- can't get their paper published.

But it's not nearly as much fun as a massive conspiracy theory:

- evil hedge funds
- evil market makers
- billions of shares naked shorted (despite any evidence whatsoever)
- big pharma trying to squash nwbo
- big pharms trying to buy nwbo cheap
- wolfpack
icon url

Reefrad

05/23/22 2:05 PM

#477592 RE: HappyLibrarian #477582

You don’t think a BLA submission PR would make a big difference?
icon url

Chiugray

05/23/22 3:14 PM

#477619 RE: HappyLibrarian #477582

The scientific discussion of primary endpoints is not a formal TLD release by the company. And the importance is not just a full TLD, more importantly, I believe it marks the start of many upcoming news events and catalysts.

On building credibility and relationship with journalists, I think being in a quiet period does not mean a lack of relationship. Instead fewer words when nothing can be said is a form of respect. And delivering actual results and proof of significant long tail surviving patients earns is the ultimate form of credibility to all parties (patients, oncologists, journalists, and readership).

To the underlying question of a low stock price, VikingInvest's post should provide some comfort to rattled retail shareholders and to those that panic-sold and thinking of buying back. NWBO communications had their hands tied behind their backs because they have been operating under a smart stealth mode and because they are surrounded by a pack of wolves. Well folks, their hands are about to be untied.
icon url

vator

05/23/22 4:14 PM

#477653 RE: HappyLibrarian #477582

Innes was supposed to be the genius. I do not blame him. He is not in charge and has to follow his marching orders.